¿Cómo Podemos Ayudarle?
Puede haber opciones para ayudarle a cubrir los gastos de Rituxan,
independientemente del tipo de seguro médico que posea.
Derivación a Fundaciones Independientes de Asistencia al Copago
Si necesita ayuda con el copago de Rituxan, Genentech Access Solutions puede derivarle a una fundación independiente de asistencia al copago.
Una fundación independiente de asistencia al copago es una
organización benéfica que proporciona asistencia financiera para
medicamentos.
Llame a Genentech Access Solutions en el (866) 681-3261 para que le deriven.
Si desea ponerse en contacto directamente con una fundación, puede usar la información que se indica a continuación:
Granulomatosis With Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)
La fundaciones independientes de asistencia al copago tienen sus
propias normas para elegibilidad. No podemos garantizarle que una
fundación le vaya a ayudar. Solo podemos derivarle para que esta le
asista con su estado de salud. Esta información solo se la
proporcionamos a modo informativo. No respaldamos ni mostramos
preferencia económica por ninguna fundación en particular. Las
fundaciones de esta lista no son las únicas que pueden ayudarle.
Derivaciones a la fundación Genentech Patient Foundation
La fundación Genentech® Access to Care Foundation ahora es Genentech Patient Foundation.
Aún nos enfocamos en proporcionar medicamentos gratuitos a los pacientes necesitados, pero hemos realizado algunos cambios para ofrecer mejor asistencia a más pacientes, más rápido.
Genentech Patient Foundation proporciona medicamentos gratuitos a las personas:
- Que no tienen seguro
- Cuyo tratamiento no está cubierto por el seguro
- Que tienen dificultades con sus elevados costos que deben abonar de su bolsillo
Para obtener más información y solicitar ayuda, visite GenentechPatientFoundation.com.
Si cuenta con cobertura de un seguro médico para su medicamento, primero debe haber probado otros tipos de asistencia a pacientes para ser apto para recibir Rituxan gratis a través de la Genentech Patient Foundation. Esto incluye el Programa de Tarjeta de Copago de Rituxan Inmunología y la ayuda de fundaciones independientes de asistencia al copago. También debe cumplir otros criterios financieros. Si no tiene seguro o si su seguro no cubre su medicamento, debe cumplir unos criterios financieros diferentes.
Derivaciones al Programa de Tarjeta de Copago de Rituxan Inmunología
Genentech Access Solutions puede derivarle al Programa de Tarjeta de Copago de Rituxan Inmunología. Si usted es elegible, puede ayudarle con los gastos de Rituxan que deba abonar de su bolsillo.
El Programa de Tarjeta de Copago de Rituxan Inmunología ayuda a los
pacientes con un seguro médico comercial. Puede que sea un plan que
obtiene a través de su empleador o uno que haya contratado en un
Mercado de Seguros Médicos como HealthCare.gov. Para poder calificar,
también debe cumplir otros criterios.
Para poder optar al Programa de Tarjeta de Copago de Rituxan
Inmunología, el paciente debe disponer de un seguro comercial, no
debe tener Medicare, Medicaid ni ningún otro seguro público y debe
cumplir otros criterios de elegibilidad. También debe aceptar las
reglas establecidas en los términos y condiciones del programa.
Visite RACopay.com para ver la lista completa de
términos y condiciones.
Cómo Trabajar con Genentech Access Solutions
Paso 2
Trabajamos con usted, con la consulta de su médico, su plan de seguro médico y su farmacia especializada. Podríamos ponernos en contacto con usted para recabar más información.
PAN=siglas en inglés de Autorización del Paciente
y Aviso de Solicitud Para Transmitir Información Médica a Genentech
Access Solutions y a Genentech® Access to Care Foundation.
SMN=siglas en inglés de Declaración de Necesidad Médica.
Important Safety Information & Indication
What it treats
What is Rituxan?
Rituxan is a prescription medicine used to treat adults with:
Rheumatoid arthritis (RA): with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA in adults, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough.
Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA): with glucocorticoids.
Pemphigus Vulgaris (PV): to treat moderate to severe PV.
It is not known if Rituxan is safe and effective in children.
Important Safety Information
Important Side Effect Information
What is the most important information I should know about Rituxan?
Rituxan can cause serious side effects that can lead to death, including:
- Infusion Reactions: Infusion reactions are very common side effects of Rituxan treatment. Serious infusion reactions can happen during your infusion or within 24 hours after your infusion of Rituxan. Your healthcare provider should give you medicines before your infusion of Rituxan to decrease your chance of having a severe infusion reaction
- Severe Skin and Mouth Reactions: Tell your healthcare provider or get medical help right away if you get any of these symptoms at any time during your treatment with Rituxan: painful sores or ulcers on your skin, lips, or in your mouth; blisters; peeling skin; rash; or pustules
- Hepatitis B Virus (HBV) Reactivation: If you have had hepatitis B or are a carrier of hepatitis B virus, receiving Rituxan could cause the virus to become an active infection again. Hepatitis B reactivation may cause serious liver problems, including liver failure and death. You should not receive Rituxan if you have active hepatitis B liver disease. Your healthcare provider will monitor you for hepatitis B infection during and for several months after you stop receiving Rituxan
- Progressive Multifocal Leukoencephalopathy (PML): PML is a rare, serious brain infection caused by a virus that can happen in people who receive Rituxan. People with weakened immune systems can get PML. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML
Before receiving Rituxan, patients should tell their healthcare provider if they:
- have had a severe infusion reaction to Rituxan in the past
- currently have or have a history of other medical conditions, especially heart disease
- have had a severe infection, currently have an infection, or have a weakened immune system
- have had a recent vaccination or are scheduled to receive vaccinations
- have taken Rituxan in the past
- are pregnant or planning to become pregnant. Females who are able to become pregnant should use effective birth control (contraception) during treatment with Rituxan and for 12 months after the last dose of Rituxan
- are breastfeeding or plan to breastfeed. Patients should not breastfeed during treatment and for at least 6 months after the last dose of Rituxan
- are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements
What are the possible side effects of Rituxan?
Rituxan can cause serious and life‐threatening side effects, including:
- Tumor Lysis Syndrome (TLS): TLS is caused by the fast breakdown of cancer cells. TLS can cause you to have kidney failure and the need for dialysis treatment or may cause an abnormal heart rhythm. Tell your healthcare provider right away if you have any of the following signs or symptoms of TLS: nausea, vomiting, diarrhea, or lack of energy
- Serious Infections: Serious infections can happen during and after treatment with Rituxan and can lead to death. Rituxan can increase you risk of getting infections and can lower the ability of your immune system to fight infections. People with serious infections should not receive Rituxan
- Heart Problems: Rituxan may cause chest pain, irregular heartbeats, and heart attack. Your healthcare provider may monitor your heart during and after treatment with Rituxan if you have symptoms of heart problems or have a history of heart problems
- Kidney Problems: especially if you are receiving Rituxan for non–Hodgkin’s lymphoma (NHL). Your healthcare provider should do blood tests to check how well your kidneys are working
- Stomach and Serious Bowel Problems That Can Sometimes Lead to Death: Tell your healthcare provider right away if you have any stomach-area pain during treatment with Rituxan
What are common side effects during treatment with Rituxan?
The most common side effects of Rituxan include:
- infusion-related reactions
- infections (may include fever, chills)
- body aches
- tiredness
- nausea
In patients with GPA or MPA, the most common side effects of Rituxan also include:
- low white and red blood cells
- swelling
- diarrhea
- muscle spasms
Other side effects with Rituxan include:
- aching joints during or within hours of receiving an infusion
- more frequent upper respiratory tract infections
These are not all of the possible side effects with Rituxan.
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at (800) FDA‐1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835‐2555.
Please see the Rituxan Prescribing Information and Medication Guide including Most Serious Side Effects for additional Important Side Effect Information.